PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for ARPI-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer: a pooled analysis of KEYNOTE-921 and CheckMate 7DX trials

International Urology and Nephrology 2026

View at publisher

Authors: Qi Zou, Qiao Yun Huang, Jiashuo Li, Qiang Li

DOI: 10.1007/s11255-026-05064-w

Cited by: 0

References: 30

Fields of Study & Subjects

Prostate Cancer Treatment and Research Cancer Immunotherapy and Biomarkers Advanced Breast Cancer Therapies

References 30